Almirall S.A
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfecti… Read more
Market Cap & Net Worth: Almirall S.A (LBTSF)
Almirall S.A (PINK:LBTSF) has a market capitalization of $1.93 Billion ($1.93 Billion) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #8872 globally and #4391 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Almirall S.A's stock price $9.01 by its total outstanding shares 214577056 (214.58 Million).
Almirall S.A Market Cap History: 2016 to 2025
Almirall S.A's market capitalization history from 2016 to 2025. Data shows change from $2.96 Billion to $1.93 Billion (-6.40% CAGR).
Almirall S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Almirall S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.00x
Almirall S.A's market cap is 2.00 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
193.98x
Almirall S.A's market cap is 193.98 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.96 Billion | $764.36 Million | $75.48 Million | 3.87x | 39.20x |
| 2017 | $2.01 Billion | $639.38 Million | -$303.96 Million | 3.15x | N/A |
| 2018 | $3.18 Billion | $756.93 Million | $77.67 Million | 4.20x | 40.93x |
| 2019 | $3.89 Billion | $855.34 Million | $105.91 Million | 4.55x | 36.76x |
| 2020 | $2.57 Billion | $1.61 Billion | $74.28 Million | 1.59x | 34.64x |
| 2021 | $2.55 Billion | $827.20 Million | -$40.86 Million | 3.08x | N/A |
| 2022 | $2.03 Billion | $863.25 Million | $4.28 Million | 2.36x | 475.12x |
| 2023 | $1.95 Billion | $894.52 Million | -$38.47 Million | 2.18x | N/A |
| 2024 | $1.97 Billion | $985.72 Million | $10.15 Million | 2.00x | 193.98x |
Competitor Companies of LBTSF by Market Capitalization
Companies near Almirall S.A in the global market cap rankings as of March 18, 2026.
Key companies related to Almirall S.A by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Almirall S.A Historical Marketcap From 2016 to 2025
Between 2016 and today, Almirall S.A's market cap moved from $2.96 Billion to $ 1.93 Billion, with a yearly change of -6.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.93 Billion | -1.78% |
| 2024 | $1.97 Billion | +0.80% |
| 2023 | $1.95 Billion | -4.00% |
| 2022 | $2.03 Billion | -20.17% |
| 2021 | $2.55 Billion | -0.97% |
| 2020 | $2.57 Billion | -33.92% |
| 2019 | $3.89 Billion | +22.47% |
| 2018 | $3.18 Billion | +57.87% |
| 2017 | $2.01 Billion | -31.94% |
| 2016 | $2.96 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Almirall S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.93 Billion USD |
| MoneyControl | $1.93 Billion USD |
| MarketWatch | $1.93 Billion USD |
| marketcap.company | $1.93 Billion USD |
| Reuters | $1.93 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.